Generic Name: fremanezumab
Brand Name: Ajovy
Manufacturer: Teva Canada Innovation
Manufacturer Requested Reimbursement Criteria1: To be confirmed later in the submission.
Submission Type: New
Project Status: Received
Companion Diagnostics: No
Fee Schedule: Pending
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
|Call for patient input open||March 30, 2020|
|Call for patient input closed||May 20, 2020|
- Patient input submission received from Migraine Canada and Migraine Quebec
|Submission received||June 03, 2020|
- Submission was not accepted for review on 17 June 2020